Dr. Lipinski graduated from the Virginia Commonwealth University SOM in 2006. He works in Washington, DC and specializes in Cardiovascular Disease. Dr. Lipinski is affiliated with Medstar Washington Hospital Center.
- Columbia MD, US Dror Luger - Columbia MD, US Michael Lipinski - Columbia MD, US
International Classification:
C07K 16/28 A61P 37/06
Abstract:
The present invention relates to CD160 binding molecules and nucleic acid sequences encoding such molecules. In particular embodiments, the present invention provides CD160 binding molecules (e.g., monoclonal antibodies or antibody fragments) with particular light chain and/or heavy chain CDRs (e.g., selected from SEQ ID NOS:2-4, 10-12, 6-8, and 14-16) and methods for using such molecules to treat an inflammatory disease, cancer, a chronic infection, and a refractory infection, or to determine whether cells with the CD160 surface receptor are present in certain tissues or cells being examined.
Medstar Washington Hospital Center Jul 2015 - Jan 2018
Interventional Cardiologist
Cardiovascular Associates of Charlottesville, Plc Jul 2015 - Jan 2018
Interventional Cardiologist
Washington Hospital Jul 2013 - Jun 2015
Interventional Cardiology Fellow
Uva Health System Jul 2008 - Jun 2013
Cardiology Fellow
Education:
University of Virginia 2008 - 2013
Doctorates, Doctor of Philosophy, Biology, Immunology, Philosophy
Virginia Commonwealth University School of Medicine 2001 - 2006
Doctor of Medicine, Doctorates, Medicine
Stanford University 1996 - 2000
Bachelors, Bachelor of Science, Biology
Georgetown University
Skills:
Atherosclerosis Interventional Cardiology Translational Research Cardiovascular Imaging Cardiology Clinical Research Medical Education Internal Medicine